Elena Giudice
9PUBLICATIONS
20CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 17, 2026
Durvalumab and cediranib with and without olaparib in recurrent ovarian cancer: a phase II proof-of-concept study.Junya Tabata, Tzu-Ting Huang, Elena Giudice
|Nov 19, 2025
Phase II proof-of-concept study of durvalumab and cediranib with and without olaparib in recurrent ovarian cancer.Jung-Min Lee, Junya Tabata, Tzu-Ting Huang
|Mar 30, 2024
The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial.Elena Giudice, Tzu-Ting Huang, Jayakumar R Nair
|Oct 04, 2023
Therapeutic Potential of Tisotumab Vedotin in the Treatment of Recurrent or Metastatic Cervical Cancer: A Short Report on the Emerging Data.Veronica Agostinelli, Lucia Musacchio, Floriana Camarda
|Feb 09, 2023
Survival outcomes in patients with <i>BRCA</i> mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors.Lucia Musacchio, Serena Boccia, Claudia Marchetti
|Feb 06, 2023
Genome tumor profiling in endometrial cancer and clinical relevance in endometrial cancer management: a retrospective single-center experience.Vanda Salutari, Viola Ghizzoni, Maria Vittoria Carbone
Pageof 2
Frequent Collaborators
3 joint publications
Domenica Lorusso
3 joint publications
Tzu-Ting Huang
3 joint publications
Nahoko Sato
3 joint publications
Bernadette Redd
2 joint publications
Camilla Nero
2 joint publications
Jung-Min Lee
2 joint publications
Giovanni Scambia
2 joint publications
Sunmin Lee
2 joint publications
Shraddha Rastogi
2 joint publications
Aanika Warner
